logo-loader
viewTHC Global Group Ltd

The Hydroponics Company new directors buy shares on market

The two directors purchased a combined $74,000+ worth of shares this week.

three empty boardroom seats
Shares in the company were last trading at 55 cents per share

The Hydroponics Company Ltd (ASX:THC) has received a vote of confidence from its two recently appointed board members, who have both recently purchased shares on market.

Lou Cattelan and Gary Radcliff were voted in by shareholders as directors of the board at an extraordinary general meeting (EGM) in March 2018.

Cattelan purchased $51,323 worth of shares at an average price of 58 cents through on-market trades this week.

Similarly, Radcliff purchased $23,369 worth of shares also through on-market trades this week.

READ: The Hydroponics Company recognises value in manufacturing facility

Radcliff is a barrister and is president of the Gold Coast Bar Association.

Cattelan is a pharmaceutical executive with over 30 years experience in technical and operations management in the pharmaceutical and related industries with organisations such as Vitaplex, Soul Pattinson, Wella and Blackmores.

Quick facts: THC Global Group Ltd

Price: 0.4 AUD

ASX:THC
Market: ASX
Market Cap: $54.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global starts manufacturing at Southport facility after green light from...

THC Global Group Ltd’s (ASX:THC) group chief executive officer Ken Charteris updates Proactive after the company received a key medicinal cannabis manufacture permit for its Southport facility from the Australia regulator, allowing production to start immediately. Charteris says this is...

6 hours, 50 minutes ago

2 min read